Immunohistochemistry panels have been suggested for suspicious malignancies which include medullary carcinoma (calcitonin, thyroglobulin, CEA, and chromogranin), anaplastic carcinoma (pan-cytokeratin), and metastatic carcinoma (TTF-1). This evidence concerns the gene TTF1 and medullary thyroid gland carcinoma.